STRATA CRITICAL MEDICAL, INC. (SRTA) Quick Ratio
- Quick ratio · latest quarter: Value 1.45×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 1.45× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $66.16M ÷ $45.78M ≈ 1.45× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 66.16M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 45.78M USD | Liabilities, Current |
| Cash and equivalents | 16.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 6.44M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 43.41M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $66.16M | $45.78M | $16.32M | $6.44M | $43.41M | (m) | 1.45× |
| 2026-03-31 | $98.39M | $20.94M | $58.72M | $66.00K | $39.60M | (m) | 4.70× |
| 2025-12-31 | $101.19M | $19.79M | $30.97M | $30.26M | $39.96M | (m) | 5.11× |
| 2025-09-30 | $113.46M | $27.87M | $22.75M | $53.16M | $37.54M | (m) | 4.07× |
| 2025-06-30 | $141.59M | $26.31M | $58.75M | $54.67M | $28.17M | (m) | 5.38× |
| 2025-03-31 | $142.13M | $21.88M | $34.83M | $85.18M | $22.13M | (m) | 6.50× |
| 2024-12-31 | $148.73M | $22.73M | $18.38M | $108.76M | $21.59M | (m) | 6.54× |
| 2024-09-30 | $160.82M | $27.18M | $20.03M | $116.31M | $24.48M | (m) | 5.92× |
| 2024-06-30 | $169.67M | $30.29M | $26.31M | $115.64M | $27.72M | (m) | 5.60× |
| 2024-03-31 | $174.52M | $23.25M | $36.76M | $114.22M | $23.55M | (m) | 7.51× |
| 2023-12-31 | $187.14M | $35.49M | $27.87M | $138.26M | $21.00M | (m) | 5.27× |
| 2023-09-30 | $194.27M | $30.36M | $36.81M | $136.41M | $21.04M | (m) | 6.40× |
| 2023-06-30 | $192.22M | $29.27M | $37.35M | $132.34M | $22.52M | (m) | 6.57× |
| 2023-03-31 | $193.41M | $23.21M | $41.74M | $135.21M | $16.46M | (m) | 8.33× |
| 2022-12-31 | $204.91M | $26.61M | $43.30M | $150.74M | $10.88M | (m) | 7.70× |
| 2022-09-30 | $213.49M | $20.23M | $51.84M | $150.38M | $11.27M | (m) | 10.56× |
| 2022-06-30 | $265.83M | $18.51M | $186.56M | $69.61M | $9.67M | (m) | 14.36× |
| 2022-03-31 | $275.07M | $15.79M | $2.50M | $266.56M | $6.02M | (m) | 17.42× |
| 2021-12-31 | $287.52M | $12.78M | $2.60M | $279.37M | $5.55M | (m) | 22.49× |
| 2021-09-30 | $307.89M | $9.53M | $6.95M | $297.18M | $3.77M | (m) | 32.30× |
| 2021-06-30 | (m) | $10.56M | $30.00M | (m) | $1.71M | (m) | (m) |
| 2021-03-31 | (m) | $1.54M | $485.22K | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $390.79K | $846.07K | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $458.35K | $889.55K | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $485.09K | $1.02M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $479.86K | $1.09M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $371.31K | $1.31M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $353.21K | $1.82M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |